Well Told Grants

Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-DP-23-001: Assessing the Effectiveness of Programs, Policies, or Practices that Affect Social Determinants of Health to Promote Health Equity and Reduce Health Disparities in Chronic Diseases

Closed Closed February 23, 2023 Opportunity RFA-DP-23-001

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2022.

Centers for Disease Control and Prevention - ERA offered grants of up to $1.0 million to any type of organization. It expected to make about 12 awards worth $28.5 million in total. Applications closed on February 23, 2023.

From the official notice on Grants.gov, last changed January 19, 2023. Checked November 7, 2026.

Key dates

PostedNovember 22, 2022
DeadlineFebruary 23, 2023
Archived by Grants.govFebruary 24, 2023

Who can apply

This opportunity was open to any type of organization.

All 15 applicant types the notice lists

For an application to be considered, the application must be responsive to these Special Eligibility Requirements. If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. Component A: Research Studies to Assess the Impact of Programs, Policies, or Practices that Address SDOH on Chronic Disease-Related Health Disparities 1. Applicants must have continuous access to data sets and/or data systems needed to accomplish study objectives and a minimum study sample size of 10,000 individuals for each priority area selected. 2. Applicants must have approval for unrestricted publication of the study findings, regardless of study outcomes. 3. Applicants may not request funding above the ceiling amount (direct and indirect) listed below: Tier 1: $600,000 Tier 2: $700,000 Tier 3: $800,000 Tier 4: $900,000 Tier 5: $1,000,000 Component B: SDOH Simulation Model Development Applicants must have access to the clinical and real-world data that are needed to develop and validate the simulation model. Applicants may not request funding above the ceiling amount of $1,000,000 (direct and indirect). Component C: Coordinating Center 1. Applicants for Component C must apply for Component A or Component B. 2. Applicants may not request funding above the ceiling amount of $500,000 (direct and indirect).

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

What the grant funds

The purpose of this NOFO is to support rapid, applied research with rigorous study design (i.e., natural experiments, quasi-experimental design studies, simulation modeling, and economic evaluations) to evaluate the impact of ongoing programs, policies, and environmental improvement strategies on SDOH and how these changes in SDOH improve chronic disease outcomes and related health disparities. The funded sites are expected to work together to create a network. This NOFO has three (3) components to achieve the purpose of the program: Component A (Research Studies to Assess Inequities in Addressing Chronic Diseases): The purpose is to support epidemiological research using studies with natural or quasi-experimental designs aimed at identifying and evaluating how inequities in chronic disease outcomes are mitigated by ongoing programs, policies, and environmental improvement strategies targeting SDOH. Component B (Studies to Assess Health and Economic Outcomes and Disparities of Chronic Diseases): The purpose is to support research that will apply a systems science approach to build simulation models of the interplay of SDOH factors and their relationship to chronic disease and health disparities, providing long-term estimates (e.g., 10-, 20-, 30-year) of chronic disease outcomes and disparities in quality-adjusted life-years, and the cost and cost-effectiveness of a policy, program, or strategy. Component C (Coordinating Center): The purpose is to support a coordinating center that provides organizational, logistic, and communication support to enhance the efficiency, productivity, and public health impact of the research centers that are funded under Components A and B. Applicants may apply for Component A or Component B. Applicants for Component C must apply for and be funded for Component A or Component B to be funded for Component C.

Category: Health.

Who has won Chronic Diseases: Research, Control, and Prevention grants before

From fiscal 2021 to 2025, Chronic Diseases: Research, Control, and Prevention (93.068) awarded $57.3 million across 88 grant awards, an average of $651,162 per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
New York UniversityNew York3$5.6 million
American College of Rheumatology, IncGeorgia1$4.9 million
Lupus Foundation of America Inc.District of Columbia1$4.8 million
National Opinion Research CenterIllinois2$3.2 million
Cicatelli Associates, Inc.New York1$3.0 million

Top states: New York ($8.8 million), Georgia ($8.4 million), District of Columbia ($6.3 million), California ($4.5 million), Illinois ($4.5 million).

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-DP-23-001 still open?

No. It closed on February 23, 2023. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.

Who can apply for Assessing the Effectiveness of Programs, Policies, or Practices that Affect Social Determinants of Health to Promote Health Equity and Reduce Health Disparities in Chronic Diseases?

Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.

What is the deadline for Assessing the Effectiveness of Programs, Policies, or Practices that Affect Social Determinants of Health to Promote Health Equity and Reduce Health Disparities in Chronic Diseases?

Closed February 23, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $1.0 million each. About $28.5 million in total across about 12 awards.

Who has won Chronic Diseases: Research, Control, and Prevention grants before?

The largest recipients over five fiscal years were New York University, American College of Rheumatology, Inc, Lupus Foundation of America Inc. The program made 88 awards worth $57.3 million in that time.

Similar open grants